07517886 is referenced by 64 patents and cites 156 patents.

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

Title
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
Application Number
10/631029
Publication Number
7517886 (B2)
Application Date
July 29, 2003
Publication Date
April 14, 2009
Inventor
Hui Li
Millbrae
CA, US
Catherine Sylvain
Burlingame
CA, US
Somasekhar Bhamidipati
Foster City
CA, US
Holger Keim
Menlo Park
CA, US
Jeffrey Clough
Redwood City
CA, US
Donald G Payan
Hillsborough
CA, US
Ankush Argade
Foster City
CA, US
Rajinder Singh
Belmont
CA, US
Agent
James J Diehl
Foley & Lardner
Assignee
Rigel Pharmaceuticals
CA, US
IPC
A61K 31/4965
View Original Source